Comparative study of HC2 and Cervista™ for the detection of HPV

Francesc Alameda, Beatriz Bellosillo, Belén Lloveras, Merce Muset, Gemma Mancebo, Fernando Larrazabal, Ramón Carreras, Sergi Serrano

Research output: Contribution to journalArticleResearchpeer-review


Introduction: HPV detection in gynaecological samples currently provides key data in cervical pathology for diagnostic and management decisions. At present HC2 is the most clinically proven method for this purpose. Methods: Comparative study of HPV-HR detection between HC2 and Cervista™. Results: The concordance between the two methods is 96.4%. The sensitivity of Cervista™ for CIN2+ is 98.3% and specificity exceeds 98.4%. Conclusions: We conclude that Cervista™ is an appropriate method for the detection of HPV-HR in gynecological samples for screening and clinical purposes. © 2011 SEAP y SEC.
Original languageEnglish
Pages (from-to)191-194
JournalRevista Espanola de Patologia
Issue number4
Publication statusPublished - 1 Oct 2011


  • Cervical pathology
  • Detection
  • Human papilomavirus (HPV)
  • Screening


Dive into the research topics of 'Comparative study of HC2 and Cervista™ for the detection of HPV'. Together they form a unique fingerprint.

Cite this